Over the past fifty years a significant body of evidence has been compiled suggesting an
interaction between the endocannabinoid (EC) system and alcohol dependence. However …

Abstract Δ 9-tetrahydrocannabinol (Δ 9-THC), the primary active component in Cannabis
sativa preparations such as hashish and marijuana, signals by binding to cell surface …

The current review evaluates the evidence that some of the pharmacological and behavioral
effects of ethanol (EtOH), including EtOH-preferring behavior, may be mediated through the …

Alcohol use disorder represents a significant human health problem that leads to substantial
loss of human life and financial cost to society. Currently available treatment options do not …

Over the past few years, advances in the investigation of the neurochemical circuits involved
in the development and treatment of alcohol dependence have identified peptides and …

This review presents the remarkable research during the past several years indicating that
some of the pharmacological and behavioral effects of alcohol, including alcohol drinking …

Recent advances in the understanding of the neurobiological basis of alcohol dependence
suggest that the endocannabinoid system may play a key role in the reinforcing effects of …

Δ9‐tetrahydrocannabinol, the principal active component in Cannabis sativa extracts such
as marijuana, participates in cell signalling by binding to cannabinoid CB1 and CB2 …

Endocannabinoids are lipid mediators that interact with the same cannabinoid receptors that
recognize Δ9‐tetrahydrocannabinol (THC), the psychoactive constituent of marijuana, to …

Research into the endocannabinoid signaling system has grown exponentially in recent
years following the discovery of cannabinoid receptors (CB) and their endogenous ligands …